“Integrated Safety Analysis of Abrocitinib in 635 Adolescent Patients With Moderate-To-Severe Atopic Dermatitis With Over 1000 Patient-Years of Exposure”. SKIN The Journal of Cutaneous Medicine 8, no. 2 (March 18, 2024): s379. Accessed April 18, 2025. https://skin.dermsquared.com/skin/article/view/2690.